EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Can carbapenem-resistant enterobacteriaceae susceptibility results obtained from surveillance cultures predict the susceptibility of a clinical carbapenem-resistant enterobacteriaceae?



Can carbapenem-resistant enterobacteriaceae susceptibility results obtained from surveillance cultures predict the susceptibility of a clinical carbapenem-resistant enterobacteriaceae?



American Journal of Infection Control 44(8): 953-955



We evaluated the susceptibility profile of a colonizing carbapenem-resistant enterobacteriaceae to predict its susceptibility when recovered from a clinical specimen. An overall agreement of 88.7% (517 out of 583; 95% confidence interval, 85.8%-91.0%) was observed for the combinations of 11 antibiotics with 53 pairs of Klebsiella pneumoniae carbapenemase-producing K pneumoniae (the only carbapenem-resistant enterobacteriaceae detected). Very major errors were observed mainly for aminoglycoside agents and colistin, limiting the predictability of the susceptibility profile for these clinical isolates.

(PDF emailed within 0-6 h: $19.90)

Accession: 057346677

Download citation: RISBibTeXText

PMID: 27021509

DOI: 10.1016/j.ajic.2016.01.037



Related references

Epidemiology of carbapenem-resistant and noncarbapenem-resistant enterobacteriaceae and issues related to susceptibility testing, treatment options, and clinical outcome. Reviews in Medical Microbiology 25(3): 53-65, 2014

Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. Journal of Clinical Microbiology 52(6): 1893-1897, 2015

Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany. Journal of Clinical Microbiology 52(8): 3135-3135, 2014

The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients. American Journal of Infection Control 41(2): 180-182, 2013

Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility. Expert Review of Anti-Infective Therapy 15(6): 519-526, 2017

Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clinic Proceedings 86(3): 250-259, 2011

Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand. Plos One 10(9): E0139116-E0139116, 2016

Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae. Journal of Hospital Infection 76(4): 355-356, 2011

Phenotypic methods for screening carbapenem-resistant Enterobacteriaceae and assessment of their antimicrobial susceptibility profile. Revista Da Sociedade Brasileira de Medicina Tropical 50(2): 173-178, 2017

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. Ebiomedicine 19: 98-106, 2017

Perianal swabs surveillance cultures of Carbapenem-resistant Enterobacteriaceae(CRE) can be hints for CRE bloodstream infection in patients with hematological diseases. Zhonghua Xue Ye Xue Za Zhi 39(12): 1021-1025, 2019

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa. Journal of Clinical Microbiology 56(2): -, 2017

Effects of breakpoint changes on carbapenem susceptibility rates of Enterobacteriaceae: Results from the SENTRY Antimicrobial Surveillance Program, United States, 2008 to 2012. Canadian Journal of Infectious Diseases & Medical Microbiology 25(5): 285-287, 2014

Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr-Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution. Journal of Clinical Microbiology 55(9): 2609-2616, 2017

Meropenem-vaborbactam: a carbapenem and beta-lactamase inhibitor with activity against carbapenem-resistant Enterobacteriaceae. European Journal of Clinical Microbiology & Infectious Diseases, 2018